About Dacihep daclatasvir Tablet
Experience the featured efficacy of Dacihep Daclatasvir Tablet, a meritorious addition to the antiviral agents designed to treat chronic Hepatitis C infection. Produced by the renowned Zydus Cadila Healthcare Ltd., this top oral medication boasts instant savings for healthcare providers and patients. Formulated with transcendent precision, each light yellow, oval, biconvex tablet contains 60 mg daclatasvir dihydrochloride, promising soaring therapeutic impact. With a shelf life of 2 years, Dacihep is suitable for adults and must be prescribed by a specialist, delivering confidence and substantial relief for HCV infection.
Additional Applications and Usage Insights
Beyond its primary indication against HCV infection, Dacihep Daclatasvir Tablet is a pivotal antiviral medication for healthcare environments, research facilities, and clinical trials evaluating HCV management approaches. Its plant application lies in pharmaceutical manufacturing, adhering to stringent standards. As a general medicine, it is solely for oral use by adults, underscoring its tailored effect and selective application in contemporary medical practices focused on viral suppression.
Supply Ability and Payment Flexibility
Dacihep Daclatasvir Tablet is delivered efficiently by leading exporters and wholesalers across India, ensuring a continuous market value supply at the lowest price point. Packaging consists of 28 tablets per box, making bulk quantities accessible as per demand. Payment terms are flexible, supporting seamless transactions for global clients. Samples can be made available upon request, allowing healthcare professionals to assess quality before committing to larger orders.
FAQ's of Dacihep daclatasvir Tablet:
Q: How should Dacihep Daclatasvir Tablet be administered for optimal results?
A: Dacihep Daclatasvir Tablet should be taken orally, typically once daily or as prescribed by a specialist. It is important to follow the recommended dosage and not to skip doses to maintain its antiviral efficacy.
Q: What is the primary indication for using Dacihep Daclatasvir Tablet?
A: Dacihep Daclatasvir Tablet is primarily indicated for the treatment of chronic Hepatitis C virus (HCV) infection in adults. It may be prescribed as part of a combination therapy based on the physician's guidance.
Q: Where is Dacihep Daclatasvir Tablet manufactured and who markets it?
A: Dacihep is manufactured in India and is marketed by Zydus Cadila Healthcare Ltd., a prominent pharmaceutical company known for its high-quality antiviral agents.
Q: When is it appropriate to consider Dacihep for treatment?
A: Dacihep should be considered under the direction of a healthcare specialist when an adult patient is diagnosed with chronic Hepatitis C infection. A confirmed prescription is required to obtain this medication.
Q: What are the storage recommendations for Dacihep Daclatasvir Tablets?
A: To retain its soaring effectiveness, Dacihep tablets should be stored in a dry place, away from moisture and direct sunlight. Proper storage helps preserve the medication's 2-year shelf life.